We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

36 hedge funds and large institutions have $38.2M invested in Cumberland Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

27% more capital invested

Capital invested by funds: $30.1M → $38.2M (+$8.05M)

0.51% more ownership

Funds ownership: 33.88% → 34.39% (+0.51%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

12% less funds holding

Funds holding: 41 → 36 (-5)

Holders
36
Holders Change
-5
Holders Change %
-12.2%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.54M
2
JAM
JW Asset Management
Florida
+$1.53M
3
SCM
Stonepine Capital Management
Oregon
+$730K
4
Ameriprise
Ameriprise
Minnesota
+$144K
5
BCM
Bridgeway Capital Management
Texas
+$99.4K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$2.62M
2
BA
Bard Associates
Illinois
-$23.9K
3
Invesco
Invesco
Georgia
-$21.8K
4
AA
Ancora Advisors
Ohio
-$20K
5
TDC
Thompson Davis & Co
Virginia
-$12.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$9.67M -$2.62M -431,455 -24%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$6M +$65.7K +10,843 +1%
SCM
3
Stonepine Capital Management
Oregon
$5.13M +$730K +120,379 +19%
BlackRock
4
BlackRock
New York
$2.9M +$2.54M +418,627 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.06M – – –
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$2.04M +$29.7K +4,901 +2%
BCM
7
Bridgeway Capital Management
Texas
$2.04M +$99.4K +16,400 +6%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.88M +$80.3K +13,240 +5%
JAM
9
JW Asset Management
Florida
$1.83M +$1.53M +252,942 +2,312%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$905K +$25.8K +4,257 +3%
BA
11
Bard Associates
Illinois
$615K -$23.9K -3,950 -4%
Invesco
12
Invesco
Georgia
$486K -$21.8K -3,600 -5%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$373K – – –
EGA
14
Eagle Global Advisors
Texas
$366K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$361K +$21.7K +3,576 +7%
UCFA
16
United Capital Financial Advisors
Texas
$254K – – –
Northern Trust
17
Northern Trust
Illinois
$178K -$10.3K -1,701 -6%
Ameriprise
18
Ameriprise
Minnesota
$165K +$144K +23,812 New
SIM
19
Spark Investment Management
New York
$156K – – –
Morgan Stanley
20
Morgan Stanley
New York
$150K +$17.2K +2,844 +15%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$141K – – –
DAM
22
Delta Asset Management
Tennessee
$83K – – –
TC
23
TFS Capital
Pennsylvania
$80K +$69.7K +11,499 New
EIM
24
Essex Investment Management
Massachusetts
$76K +$66.3K +10,945 New
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$73K – – –
1
2

CPIX Hedge Fund Activity: Q1 2017 in Review

36 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2017, worth a combined $38.2M — up 27% from $30.1M a quarter earlier.

Fund positioning in CPIX was balanced in Q1 2017: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $2.54M. The largest seller was Ariel Investments, cutting an estimated $2.62M.

  • 36 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2017, down from 41 in Q4 2016.
  • Funds reported $38.2M of Cumberland Pharmaceuticals stock for Q1 2017, up 27% quarter-over-quarter.
  • 4 funds opened new Cumberland Pharmaceuticals positions in Q1 2017 and 4 closed out, a net change of 0 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $2.54M added.
  • The largest Cumberland Pharmaceuticals seller in Q1 2017 was Ariel Investments, an estimated $2.62M sold.

Based on aggregated 13F filings for Q1 2017.